BEAM vs V · rev $63.5M vs P/E 33, rev $40.00B
Beam Therapeutics Inc (BEAM) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
BEAM currently screens at market cap $2.01B. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the BEAM and V stock pages for the full models.
Not investment advice.